Pharmacogenomic Effect/ADR for Desipramine (DBSNPE005241)

Identifier
DBSNPE005241
Drug
Desipramine (DB01151)
Interacting Gene/Enzyme
Cytochrome P450 2D6
Gene Name
CYP2D6
UniProt ID
P10635
Defining Change(s)
100C>Trs1065852
-1426C>TNot Available
variable number of A’s in the region -1258 to -1237aNot Available
-1235A>GNot Available
-1000G>ANot Available
1039C>TNot Available
1661G>CNot Available
gene conversion to CYP2D7 in exon 9Not Available
4180G>CNot Available
Allele Name
CYP2D6*36
Genotype(s)
Not Available
Type(s)
Effect Inferred
Groups
Non-functional CYP2D6
Description
Poor drug metabolizer. For individual with two non-functional alleles, alternative drug or dose reduction recommended.
References
  1. Hicks JK, Sangkuhl K, Swen JJ, Ellingrod VL, Muller DJ, Shimoda K, Bishop JR, Kharasch ED, Skaar TC, Gaedigk A, Dunnenberger HM, Klein TE, Caudle KE, Stingl JC: Clinical pharmacogenetics implementation consortium guideline (CPIC) for CYP2D6 and CYP2C19 genotypes and dosing of tricyclic antidepressants: 2016 update. Clin Pharmacol Ther. 2016 Dec 20. doi: 10.1002/cpt.597. [PubMed:27997040]